AAV-based gene therapy (University of Pittsburgh/Astellas)

N/A

Report date: 2025/01/26 18:11:37

Base Information

Drug NameAAV-based gene therapy (University of Pittsburgh/Astellas)
Drug Alias Nameadeno-associated virus-based gene therapy (University of Pittsburgh/Astellas)
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pittsburgh
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A